Macleods files reply in support of judgment on the pleadings in Amgen patent case
( October 2, 2017, 22:31 GMT | Official Statement) -- MLex Summary: Macleods Pharmaceuticals has filed a reply in support of its motion for judgment on the pleadings in its favor with respect to Amgen's claims that Macleods infringed Amgen's patents. "Amgen's opposition contains nothing more than mere distraction and shallow attempts to drum up 'issues of fact' that are not germane to the questions of law presented by Macleods," Macleods said.See document below. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.